Skip to main navigation Skip to search Skip to main content

Patient-Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo-Controlled, Double-Blind and 32-Week Open-Label Study

  • on behalf of the ELECT Study Group

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Patient-Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo-Controlled, Double-Blind and 32-Week Open-Label Study'. Together they form a unique fingerprint.
Sort by

Nursing and Health Professions

Medicine and Dentistry